The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis

References

• Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. DESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035–87.
   Google Scholar
• Anselmino M, Gohlke H, Mellbin L, Rydén L. Cardiovascular prevention in patients with diabetes and prediabetes. Herz. 2008;33(3):170–7.10.1007/s00059-008-3105-5
   PubMed Web of Science ®Google Scholar
• Iglesias P, Pedro-Botet J, Arrieta F, Aguilar M, Escobar F. On Behalf Of The Working Group On Diabetes And Cardiovascular Disease Of The Spanish Society Of Diabetes F. Clinical significance of the new cardiovascular risk markers in diabetes mellitus. Curr Diabetes Rev. 2015; 11(4):273–80
   PubMedGoogle Scholar
• Hamad IA, Beaney KE, Buxton JL, Walker AP. Double trouble: T2DM genetic risk factors play a causal role in CAD. Atherosclerosis. 2015; 241(2):766–8
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li X, Tang S. Retrospective analysis of the relationship between elevated plasma levels of TXNIP and carotid intima-media thickness in subjects with impaired glucose tolerance and early Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015; 109(2):372–7
   PubMed Web of Science ®Google Scholar
• Rezende PC, Rahmi RM, Uchida AH, da Costa LM, Scudeler TL, Garzillo CL, et al. Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients. Cardiovasc Diabetol. 2015;14(1):1047–74.10.1186/s12933-015-0228-x
   Web of Science ®Google Scholar
• Toro R, Segura E, Nuñez-Cortes JM, Pedro-Botet JC, Quezada-Feijoo M, Mangas A. Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten target. J Geriatr Cardiol. 2015;12(2):93–9.
   PubMedGoogle Scholar
• Eriksson L, Nyström T. Antidiabetic Agents and Endothelial Dysfunction - Beyond Glucose Control. Basic Clin Pharmacol Toxicol. 2015; 117(1):15-25
   PubMed Web of Science ®Google Scholar
• Rubinat E, Marsal JR, Vidal T, Cebrian C, Falguera M, Vilanova MB, Betriu À, Fernández E, Franch J, Mauricio D. Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus. J Cardiovasc Nurs. 2015 [ Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Poudyal H, Brown L. Osteoporosis and its association with non-gonadal hormones involved in hypertension, adiposity and hyperglycaemia. Curr Drug Targets. 2013;14(14):1694–706.10.2174/1389450119999990001
   PubMed Web of Science ®Google Scholar
• Ndip A, Wilkinson FL, Jude EB, Boulton AJ, Alexander MY. RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy. Diabetologia. 2014;57(11):2251–60.10.1007/s00125-014-3348-z
   PubMed Web of Science ®Google Scholar
• Augoulea A, Vrachnis N, Lambrinoudaki I, Dafopoulos K, Iliodromiti Z, Daniilidis A, et al. Osteoprotegerin as a marker of atherosclerosis in diabetic patients. Int J Endocrinol. 2013;2013, 182060.
   Web of Science ®Google Scholar
• Aurelian SM, Cheţa DM, Onicescu D. Microvesicles — potential biomarkers for the interrelations atherosclerosis/type 2 diabetes mellitus. Rom J Morphol Embryol. 2014;55(3 Suppl):1035–9.
   PubMed Web of Science ®Google Scholar
• Wu ZH, Ji CL, Li H, Qiu GX, Gao CJ, Weng XS. Membrane microparticles and diseases. Eur Rev Med Pharmacol Sci. 2013;17(18):2420–7.
   PubMed Web of Science ®Google Scholar
• Zhang X, McGeoch SC, Johnstone AM, Holtrop G, Sneddon AA, MacRury SM, et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis. 2014;37(4):455–63.10.1007/s11239-013-1000-2
   PubMed Web of Science ®Google Scholar
• Kurtzman N, Zhang L, French B, Jonas R, Bantly A, Rogers WT, et al. Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus. Cytometry B Clin Cytom. 2013;84(4):255–66.10.1002/cyto.b.v84b.4
   PubMed Web of Science ®Google Scholar
• Tetta C, Bruno S, Fonsato V, Deregibus MC, Camussi G. The role of microvesicles in tissue repair. Organogenesis. 2011;7(2):105–15.10.4161/org.7.2.15782
   PubMed Web of Science ®Google Scholar
• Martinez MC, Andriantsitohaina R. Microparticles in angiogenesis: therapeutic potential. Circ Res. 2011;109:110–19.10.1161/CIRCRESAHA.110.233049
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97–111.
   PubMedGoogle Scholar
• Bluemke DA, Achenbach S, Budoff M, Gerber TC, Gersh B, Hillis LD, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation. 2008;118:586–606.10.1161/CIRCULATIONAHA.108.189695
   PubMed Web of Science ®Google Scholar
• Preiss D, Kristensen SL. The new pooled cohort equations risk calculator. Can J Cardiol. 2015;31(5):613–9.10.1016/j.cjca.2015.02.001
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010;77(6):502–14.10.1002/cyto.a.v77a:6
   PubMed Web of Science ®Google Scholar
• Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F. The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost. 2013 [ Epub ahead of print]
   Web of Science ®Google Scholar
• Leroyer AS, Tedgui A, Boulanger CM. Microparticles and type 2 diabetes. Diabetes Metab. 2008;34(1):S27–S32.10.1016/S1262-3636(08)70100-9
   Google Scholar
• Jung C, Shemyakin A, Böhm F, Pernow J. Endothelial microparticles in patients with insulin resistance. Diabetes Metab. 2009;35(1):71–3. doi:10.1016/j.diabet.2008.10.001.
   PubMed Web of Science ®Google Scholar
• Tooke JE, Goh KL. Endotheliopathy precedes type 2 diabetes. Diabetes Care. 1998;21(12):2047–49.10.2337/diacare.21.12.2047
   PubMed Web of Science ®Google Scholar
• Arderiu G, Peña E, Badimon L. Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation. Arterioscler Thromb Vasc Biol. 2015;35(2):348–57. doi:10.1161/ATVBAHA.114.303927.
   PubMed Web of Science ®Google Scholar
• Lichtenauer M, Goebel B, Fritzenwanger M, Förster M, Betge S, Lauten A, Figulla HR, Jung C. Simulated temporary hypoxia triggers the release of CD31+/Annexin+ endothelial microparticles: A prospective pilot study in humans. Clin Hemorheol Microcirc. 2015; 61(1):83-90.
   PubMed Web of Science ®Google Scholar
• Berezin AE, Kremzer AA, Samura TA, Martovitskaya YV. Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes. Int Cardiovasc Res J. 2014;8(3):116–23.
   PubMedGoogle Scholar
• Berezin AE, Kremzer AA. Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: Relevance to body mass index. Diabetes Metab Syndr. 2015 [ Epub ahead of print]
   Google Scholar
• Agouni A, Andriantsitohaina R, Martinez MC. Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components. Curr Vasc Pharmacol. 2014;12(3):483–92.10.2174/1570161112666140423223148
   PubMed Web of Science ®Google Scholar
• Fan Y, Wang L, Li Y, Yin Z, Xu Z, Wang C. Quantification of endothelial microparticles on modified cytometric bead assay and prognosis in chest pain patients. Circ J. 2014;78(1):206–14.10.1253/circj.CJ-13-0488
   PubMed Web of Science ®Google Scholar
• Wang CC, Tseng CC, Hsiao CC, Chang HC, Chang LT, Fang WF, et al. Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer. Biomed Res Int. 2014;2014, 173401. doi:10.1155/2014/173401.
   Web of Science ®Google Scholar
• Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res. 2013;2013, 734509. doi:10.1155/2013/734509.
   PubMedGoogle Scholar
• Suades R, Padró T, Alonso R, López-Miranda J, Mata P, Badimon L. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients. Thromb Haemost. 2014;111(1):111–21. doi:10.1160/TH13-07-0612.
   PubMed Web of Science ®Google Scholar
• Cui Y, Zheng L, Jiang M, Jia R, Zhang X, Quan Q, et al. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Mol Biol Rep. 2013;40(11):6437–42.10.1007/s11033-013-2758-1
   PubMed Web of Science ®Google Scholar